FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

126097006: Ethinylestradiol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2153823018 Ethinylestradiol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2154830016 Ethinyl estradiol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3482238011 Ethinylestradiol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
58211000195119 etinilestradiolo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
810221000172112 éthinylestradiol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
73281000195119 Ethinylestradiol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ethinylestradiol Is a Norsteroid true Inferred relationship Some
Ethinylestradiol Is a estrogeno false Inferred relationship Some
Ethinylestradiol Is a Synthetic steroid false Inferred relationship Some
Ethinylestradiol Is a Combination oral contraceptive agent false Inferred relationship Some
Ethinylestradiol Is a Estradiol false Inferred relationship Some
Ethinylestradiol Is a agent contraceptif oral false Inferred relationship Some
Ethinylestradiol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Estrogen false Inferred relationship Some
Ethinylestradiol Is a Estrane false Inferred relationship Some
Ethinylestradiol This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Estradiol false Inferred relationship Some
Ethinylestradiol Is a Estradiol and/or estradiol derivative true Inferred relationship Some
Ethinylestradiol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Gonadal hormone false Inferred relationship Some
Ethinylestradiol Is a Substance with estrogen receptor agonist mechanism of action (substance) true Inferred relationship Some
Ethinylestradiol This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Estrogen receptor agonist true Inferred relationship Some
Ethinylestradiol Is a Steroid hormone true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing only ethinylestradiol and norgestrel in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol and segesterone only product in vaginal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Product containing only drospirenone and ethinylestradiol in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Cyproterone and ethinylestradiol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 20 microgram and levomefolate calcium 451 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing only drospirenone and ethinylestradiol and levomefolic acid (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Product containing only ethinylestradiol and ferrous fumarate and norethisterone in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Drospirenone and ethinylestradiol and levomefolic acid only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Drospirenone- and ethinylestradiol- and levomefolic acid-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol- and ferrous fumarate- and norethisterone-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 20 microgram and ferrous fumarate 75 mg and norethisterone 1 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and ferrous fumarate 75 milligram and norethisterone 1.5 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 250 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and gestodene 75 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 250 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely drospirenone 3 milligram and ethinylestradiol 30 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 30 microgram and ferrous fumarate 75 mg and norgestrel 300 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 20 microgram and levonorgestrel 100 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 50 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and levonorgestrel 125 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 35 microgram and norethisterone 400 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 35 microgram and norethisterone 1 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 30 microgram and norgestrel 300 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 35 microgram and norethisterone 750 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely desogestrel 100 microgram and ethinylestradiol 25 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 5 microgram and norethisterone acetate 1 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 35 microgram and norgestimate 180 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Drospirenone 3 mg and ethinylestradiol 20 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 35 microgram and norgestimate 215 microgram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol 20 microgram and levonorgestrel 90 microgram oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 30 microgram and norethisterone acetate 1 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Ethinylestradiol Inferred relationship Some 1
Product containing precisely ethinylestradiol 10 microgram and norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1
Ethinylestradiol betadex clathrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Ethinylestradiol Inferred relationship Some
Drospirenone 3 mg and ethinylestradiol (as ethinylestradiol betadex clathrate) 20 microgram oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Ethinylestradiol Inferred relationship Some 1

Start Previous Page 4 of 4


Reference Sets

GB English

US English

Back to Start